Central Proteina Prima Tbk (CPRO) Fair Value & Analysis
Consumer Defensive · ID · Market cap 3.0T IDR
Fair value as of: Aug 13, 2026
From 25 valuation models · updated 6 days ago
Fair value updated Aug 13, 2026, revised from 125.94 IDR to 99.09 IDR (−21.3%) since Jul 16, 2026.
A solid business, screening 98% undervalued on our models.
What matters now
- The price is below even our cautious bear case (57.58 IDR). The market is more pessimistic than our downside scenario.
- Solid quality (55/100) at a price below fair value, the discount is the argument here, not the business quality.
- A fairly wide model range (57.58 IDR to 140.66 IDR) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range 50.00 IDR – 126.00 IDR · fair‑value band 57.58 IDR – 140.66 IDR · the 50.00 IDR price screens below the 99.09 IDR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Central Proteina Prima Tbk (CPRO) currently trades at 50.00 IDR, while our model-based Fair Value estimate is 99.09 IDR, implying the stock looks roughly 98.2% undervalued today. The Quality Score stands at 55/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Central Proteina Prima Tbk generated revenue of 10.0T IDR at a net margin of 3.6%. Revenue grew 3.1% year over year. It earns a return on equity of 9.6%. Net debt stands at 1.5T IDR. Fundamentals as of Aug 13, 2026
Our scenario range runs from 57.58 IDR (bear case) to 140.66 IDR (bull case); at 50.00 IDR, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 43% below its 52-week high, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at 97% fair-value upside, at 98%, CPRO screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 25 models by family
Widest divergence: Multiples (149.34 IDR) versus Dividend Discount (0.0700 IDR). Highest evidence: Growth DCF (80).
Notify me when CPRO reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 53 · Market factors (momentum, volatility) 32
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
PT Central Proteina Prima Tbk, together with its subsidiaries, operates as an integrated aquaculture shrimp and food producer company in Indonesia, India, Vietnam, China, Japan, the United States, Canada, the United Kingdom, Belgium, France, the Netherlands, Germany, and New Zealand. The company operates through Feeds, Food Products, and Others segments.
Full company description
PT Central Proteina Prima Tbk, together with its subsidiaries, operates as an integrated aquaculture shrimp and food producer company in Indonesia, India, Vietnam, China, Japan, the United States, Canada, the United Kingdom, Belgium, France, the Netherlands, Germany, and New Zealand. The company operates through Feeds, Food Products, and Others segments. It engages in the industry, livestock and agriculture, farming, hatchery, and trading and services, as well as production and trading of shrimp, fish feeds and pet food. The company also offers shrimp feed, fish feed, cat food, dog food, fish food, bird food, rabbit food, probiotic products, fish additives, disinfectants, fish hatchery, shrimp hatchery, medicines for shrimp and fish, and probiotic for shrimp medicines, as well as is involved in the cold storage and trading of shrimp, and an investment holding business. The company was formerly known as PT Central Proteinaprima Tbk and changed its name to PT Central Proteina Prima Tbk in June 2014. The company was incorporated in 1980 and is headquartered in Jakarta Selatan, Indonesia.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Central Proteina Prima Tbk reported revenue of 9.9T IDR in FY2025 versus 8.0T IDR in FY2021, a compound +5.5%/yr. Reported net income was 424B IDR in FY2025, compounding −33.8%/yr from FY2021.
Watch CPRO: get an alert when its fair value changes →
Peer Group
Farm Products · 302 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Farm Products median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Insider activity: 35/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Farm Products stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Muyuan Foods Group 002714 | ¥40.15 | ¥47.42 | +18% |
| Charoen Pokphand Foods Public Company CPF | 21.90 THB | 43.24 THB | +97% |
| PT Charoen Pokphand Indonesia Tbk, CPIN | 2,960 IDR | 6,818 IDR | +130% |
| PT Triputra Agro Persada Tbk TAPG | 1,805 IDR | 3,087 IDR | +71% |
| PT FAP Agri Tbk FAPA | 7,350 IDR | 6,420 IDR | -13% |
| PT Japfa Comfeed Indonesia Tbk JPFA | 2,260 IDR | 6,974 IDR | +209% |
| PT Jhonlin Agro Raya Tbk JARR | 1,890 IDR | 610.80 IDR | -68% |
| PT Nusantara Sawit Sejahtera Tbk NSSS | 860.00 IDR | 402.24 IDR | -53% |
| PT Sinar Mas Agro Resources and Technology Tbk SMAR | 5,625 IDR | 16,227 IDR | +188% |
| PT Dharma Satya Nusantara Tbk DSNG | 1,320 IDR | 2,696 IDR | +104% |
Compare Central Proteina Prima Tbk with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Central Proteina Prima Tbk (CPRO) overvalued or undervalued?
What is the fair value of CPRO?
What is the quality score of CPRO?
What is the revenue of Central Proteina Prima Tbk (CPRO)?
What is the net profit margin of CPRO?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Central Proteina Prima Tbk and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.